- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03357003
Tramadol Clinical Efficiency and Tolerance Correlated to O-desmethyltramadol/Tramadol Ratio (CLINCYTRAM) (CLINCYTRAM)
Observational Study (and Blood Samples Without Genetics Analysis) Tramadol Clinical Efficiency and Tolerance Correlated to O-desmethyltramadol/Tramadol Ratio (CLINCYTRAM)
Tramadol is a grade II analgesics as World Health Organization definition. It can both be an agonist on mu receptors, which provides it a low opioid action, and also be a Serotonin-norepinephrine reuptake inhibitor, which act on neuropathic pain.
Tramadol is metabolized by P450 2D6 cytochrome (CYP2D6) in O-desmethyltramadol (O-dt) which is the most active form on the pharmacologic side (analgesic effect 2 to 4 times more powerful than tramadol itself).
In caucasian population, 5 to 10% of patients are genetically qualified as "poor metabolizer phenotype"; this status is correlated to a lower analgesic efficiency compared to "rapid metabolizer".
A multicenter study, CYTRAM, is under publication and allowed measurement of blood ratio O-dT/tramadol as a way to know the phenotype of CYP2D6 to detect "poor metabolizer phenotype" status.
Indeed, blood ratio O-dT/tramadol threshold under 0.1 detects " poor metabolizer phenotype " status for postoperative patients treated by tramadol, with a good sensibility (87,5%) and specificity (83.8%).
Which impacts for current practice? The next step is to know if this blood ratio is linked to an analgesic efficiency and a good tolerance for tramadol. A "poor metabolizer phenotype" patient would have no benefit of tramadol posology increasing. Therefore, phenotype detection, thank to blood ratio, could allow to switch quickly tramadol to another analgesic treatment for "poor metabolizer phenotype" patients.
The main objective of the study is to forge a link between O-dT/tramadol ratio and analgesic efficiency. Secondary objectives investigate side effects and frequency related to O-dT/tramadol ratio and pain relief, and also impact of CYP2D6 - inhibitor treatments on the blood ratio.
If there is a correlation between this blood ratio and treatment efficiency and tolerance, O-dT/tramadol ratio's detection will allow a better adaptation for some treatments metabolized by CYP2D6. Therefore, this evolution will contribute to health quality and health safety improvement.
Studieöversikt
Studietyp
Inskrivning (Förväntat)
Kontakter och platser
Studieorter
-
-
-
Caen, Frankrike
- Rekrytering
- Caen University Hospital
-
Kontakt:
- AS Jossomme, MD
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria:
- Patients >18 years old treated by tramadol for at least 48h
- Tramadol posology between 100 and 400 mg/d (oral treatment) and until 600 mg/d (veinous treatment), recommended dosage
- Patients with nociceptive pain, definite etiology, combined or not with neuropathic pain
- Caucasian patient
- Patient able to give his/her informed consent
- Patient able to estimate himself/herself pain with pain scale for at least 48h
Exclusion Criteria:
- Age < 18 years old
- Patient with chronic pain (>3 month) or not definite
- Tramadol posology >400 mg/d (oral treatment) or > 600 mg/d (veinous treatment)
- Patients with absolute Tramadol contraindication
- Chronic endstage kidney failure antecedent (Cl cockcroft < 10mL/min) and liver failue antecedent
- Concomitant analgesic treatment, except paracetamol or stopped less than 48h ago
- Pregnant or breast-feeding patient
Studieplan
Hur är studien utformad?
Designdetaljer
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
---|---|
Ratio measurement : O-desmethyltramadol blood concentration/ tramadol blood concentration
Tidsram: at 48 hours
|
at 48 hours
|
visual analogic pain scale (1 to 10)
Tidsram: at 48 hours
|
at 48 hours
|
Samarbetspartners och utredare
Sponsor
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Förväntat)
Avslutad studie (Förväntat)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Andra studie-ID-nummer
- CaenUH
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Smärta
-
Korea University Anam HospitalKorea UniversityAvslutadSmärtmätning | Visual Analog Pain Scale
-
Alanya Alaaddin Keykubat UniversityAvslutadSterilisering, Tubal | Visual Analog Pain Scale
-
Turkish Ministry of Health, Kahramanmaras Provincial...RekryteringVisual Analog Pain ScaleKalkon
-
Ankara UniversityAvslutadSmärtmätning | Visual Analog Pain ScaleKalkon
-
East Carolina UniversityIndragen
-
University Hospital, GrenobleAvslutadDövhet | Visual Analog Pain ScaleFrankrike
-
Moens MaartenRekryteringMisslyckad Ryggkirurgi Syndrom | Persistent Spinal Pain Syndrome Typ 2Belgien
-
Moens MaartenVrije Universiteit BrusselRekryteringRyggmärgsstimulering | Persistent Spinal Pain Syndrome Typ 2Belgien
-
Örebro University, SwedenAvslutadPostoperativ smärtintensitet | Rescue Pain KravSverige
-
Wake Forest University Health SciencesRekryteringPhantom Limb Pain (PLP)Förenta staterna
Kliniska prövningar på Observational study
-
St. Louis UniversityAktiv, inte rekryterandeVertebral artärstenosFörenta staterna
-
Clinical Research Centre, MalaysiaHospital Queen Elizabeth, MalaysiaAvslutadCovid19 | Kritiskt sjukMalaysia
-
Radicle ScienceAvslutadKognitiv funktionFörenta staterna
-
Radicle ScienceRekryteringKognitiv funktionFörenta staterna
-
Tampere University HospitalAvslutad
-
University of MichiganAvslutad
-
Scion NeuroStimAnmälan via inbjudanParkinsons sjukdom | Parkinsons sjukdom och ParkinsonismFörenta staterna
-
Apple Inc.Stanford UniversityAvslutadFörmaksflimmer | Arytmier, hjärt | FörmaksfladderFörenta staterna
-
Boston Scientific CorporationAvslutadVentrikulär takykardiAustralien